Children born moderately (32-33 weeks) or late preterm (34-36 weeks) have higher long-term risks of neurodevelopmental difficulties that can affect their behavior and ability to learn, finds a study of over one million children published by The BMJ today.
ESCAPE-MeVO trial advances understanding of stroke treatment for medium-sized vessel blockages
University of Calgary’s Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving
February 7, 2025